- $14.23bn
- $27.27bn
- $2.61bn
- 42
- 87
- 85
- 83
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 9.91 | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | -7.24% | ||
Dividend Yield (f) | 8.73% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.11 | ||
Price to Tang. Book | 1.11 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 4.84 | ||
EV to EBITDA | 18.89 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 5.33% | ||
Return on Equity | 13.38% | ||
Operating Margin | 49.15% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 1,528 | 1,511 | 1,820 | 2,096 | 2,614 | 3,018.14 | 3,122.03 | 14.35% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -7.79 | -38.53 | +216.08 | -64.64 | +110.03 | -11.87 | -6.65 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Ares Capital Corporation is a specialty finance company focused on providing direct loans and other investments in private middle market companies in the United States. The Company invests primarily in first lien senior secured loans (including unitranche loans, which are loans that combine both senior and subordinated debt, generally in a first lien position), and second lien senior secured loans. In addition to senior secured loans, it also invests in subordinated debt, which in some cases includes an equity component, and preferred equity. It also may invest up to 30% of its portfolio in non-qualifying assets. Its investment activities are focused on industries, such as software and services, health care services, commercial and professional services, financial services, commercial and professional services, insurance Services, energy, food and beverage and others. Its investment adviser is Ares Capital Management LLC.
Directors
- Michael Arougheti CCH (48)
- Bennett Rosenthal CCH (58)
- Mitchell Goldstein CPR (54)
- Michael Smith CPR (49)
- Robert deVeer CEO (48)
- Penelope Roll CFO (55)
- Scott Lem CAO (44)
- Lisa Morgan CCO (45)
- Joshua Bloomstein VPR (48)
- Miriam Krieger VPR (44)
- Naseem Sagati Aghili VPR (40)
- Michael Weiner VPR (69)
- Eric Siegel LED (63)
- Robert Rosen DRC (74)
- Ann Bates IND (64)
- Daniel Kelly IND (69)
- Steven McKeever IND (60)
- Michael Parks IND (61)
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- April 16th, 2004
- Public Since
- October 8th, 2012
- No. of Shareholders
- 1,053
- No. of Employees
- 2,800
- Sector
- Collective Investments
- Industry
- Financials
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 646,076,139
- Address
- 245 Park Avenue, 44Th Floor, NEW YORK, 10167
- Web
- https://www.arescapitalcorp.com/
- Phone
- +1 2127507300
- Contact
- John Stilmar
- Auditors
- KPMG LLP
Upcoming Events for ARCC
Q4 2024 Ares Capital Corp Earnings Release
Q1 2025 Ares Capital Corp Earnings Release
Ares Capital Corp Annual Shareholders Meeting
Similar to ARCC
Arrowmark Financial
NASDAQ Global Select Market
Fidus Investment
NASDAQ Global Select Market
Gladstone Capital
NASDAQ Global Select Market
Gladstone Investment
NASDAQ Global Select Market
Horizon Technology Finance
NASDAQ Global Select Market
FAQ
As of Today at 18:20 UTC, shares in Ares Capital are trading at $22.02. This share price information is delayed by 15 minutes.
Shares in Ares Capital last closed at $22.02 and the price had moved by +10.99% over the past 365 days. In terms of relative price strength the Ares Capital share price has underperformed the S&P500 Index by -15.23% over the past year.
The overall consensus recommendation for Ares Capital is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Ares Capital dividend yield is 8.72% based on the trailing twelve month period.
Last year, Ares Capital paid a total dividend of $1.92, and it currently has a trailing dividend yield of 8.72%.Looking ahead, shares in Ares Capital are due to go ex-dividend on 2024-12-13 and the next dividend pay date is 2024-12-30.
Ares Capital are due to go ex-dividend on 2024-12-13 and the next dividend pay date is 2024-12-30. The historic dividend yield on Ares Capital shares is currently 8.72%.
To buy shares in Ares Capital you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $22.02, shares in Ares Capital had a market capitalisation of $14.23bn.
Here are the trading details for Ares Capital:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: ARCC
Based on an overall assessment of its quality, value and momentum Ares Capital is currently classified as a Turnaround. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Ares Capital is $22.46. That is 2% above the last closing price of $22.02.
Analysts covering Ares Capital currently have a consensus Earnings Per Share (EPS) forecast of $2.36 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ares Capital. Over the past six months, its share price has underperformed the S&P500 Index by -8.32%.
As of the last closing price of $22.02, shares in Ares Capital were trading +5.67% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Ares Capital PE ratio based on its reported earnings over the past 12 months is 9.91. The shares last closed at $22.02.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Ares Capital's management team is headed by:
- Michael Arougheti - CCH
- Bennett Rosenthal - CCH
- Mitchell Goldstein - CPR
- Michael Smith - CPR
- Robert deVeer - CEO
- Penelope Roll - CFO
- Scott Lem - CAO
- Lisa Morgan - CCO
- Joshua Bloomstein - VPR
- Miriam Krieger - VPR
- Naseem Sagati Aghili - VPR
- Michael Weiner - VPR
- Eric Siegel - LED
- Robert Rosen - DRC
- Ann Bates - IND
- Daniel Kelly - IND
- Steven McKeever - IND
- Michael Parks - IND